Cancer Breast Cancer

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Breast Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Breast Cancer Projects
--Amgen Inc
--AEterna Zentaris Inc
--AstraZeneca Plc
--APP Pharmaceuticals, Inc.
--Eli Lilly & Co
--Bristol-Myers Squibb Company
--Genentech Inc
--Epeius Biotechnologies Corporation
--GlaxoSmithKline plc
--Genzyme Corporation
--Johnson & Johnson
--Ipsen Ltd
--Kosan Biosciences Incorporated
--Keryx Biopharmaceuticals Inc
--Roche Holdings Ltd
--Pfizer Inc
--Schering-Plough Corp
--Sanofi-Aventis
--Wyeth
--Taiho Pharmaceutical Co., Ltd.

--Top Companies in early stage Breast Cancer Projects
--Anavex Life Sciences Corp.
--Alchemgen Therapeutics Inc.
--Ariad Pharmaceuticals Inc
--Aphios Corporation
--Bayer Schering Pharma AG
--ARIUS Research Inc
--Bionovo Inc
--BioLife Science, Inc
--Bristol-Myers Squibb Company
--BioWa, Inc.
--EntreMed Inc
--ENKAM Pharmaceutical A/S
--Kyowa Hakko Kogyo Co., Ltd.
--Introgen Therapeutics Inc
--Pharmexa A/S
--Peregrine Pharmaceuticals Inc
--Topotarget A/S
--Targa Therapeutics Corp.
--WILEX AG
--ViroTarg Pty Ltd

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View